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Abstract The yeast gene, ACPI, encoding the mitochondrial 
acyl carrier protein, was deleted by gene replacement. The 
resulting acpl-deficient mutants had only 5-10% of the wild-type 
lipoic acid content remaining, and exhibited a respiratory-
deficient phenotype. Upon meiosis, the lipoate deficiency co-
segregated with the acpl deletion. The role of ACPI in long-
chain fatty acid synthesis was studied in fasl and fas2 null 
mutants completely lacking cytoplasmic fatty acid synthase. 
When grown on odd-chain (13:0 and 15:0) fatty acids, these cells 
showed less than 1% of C-16 and C-18 acids in their total lipids. 
Mitochondrial ACP is therefore suggested to be involved with the 
biosynthesis of octanoate, a precurser to lipoic acid. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Acyl carrier protein (ACP) is a characteristic, low molecular 
mass component of non-aggregated type II fatty acid synthase 
(FAS) and polyketide synthase (PKS) systems [1,2]. It acts as 
central carrier of substrates, intermediates and products in the 
FAS and P K S biosynthetic sequences. The respective acyl 
groups are covalently linked, as thioesters, to the 4-phospho-
pantetheine prosthetic group of ACP. In addition, A C P par-
ticipates in bacterial phospholipid biosynthesis [3] as well as in 
the formation of membrane-bound oligosaccharides in Esche-
richia coli [4]. A specific A C P variant is required, in Rhizobium 
leguminosarum, for the production of a host specificity-confer-
ring lipooligosaccharide [5]. In plant chloroplasts, multiple 
A C P isoforms are possibly responsible for differential and 
tissue-specific FAS activities [6]. Depending on the activity 
of distinct accessory enzymes, specific side products of bacte-
rial fatty acid synthesis such as 3-hydroxymyristic or lipoic 
acid are presumed to be synthesized as ACP-bound deriva-
tives [1]. The functional diversity of A C P in bacterial cells is 
underscored further by the finding that, in E. coli, it even 
appears to be required for correct chromosome partitioning 
during cell division [7]. 
Due to the integrated structure of eucaryotic type I F A S 
multienzymes, there is no distinct, low molecular mass A C P in 
the eucaryotic cytoplasm. However, a bacterial-type A C P is 
found in eucaryotic organelles such as chloroplasts and mito-
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chondria [8-13]. The organellar localization of these acyl car-
rier proteins is manifested by the occurrence of typical organ-
ellar import sequences in front of the known A C P core 
sequence. In the chloroplasts of green plants, A C P is part of 
an organellar type II FAS system providing the rest of the cell 
with the required long-chain fatty acids [14]. In contrast, no 
significant amount of de novo long-chain fatty acid synthesis 
has been demonstrated in mitochondria and, therefore, the 
biochemical function of mitochondrial A C P (mtACP) is un-
known, so far. In Neurospora crassa, m t A C P is associated 
with complex I of the respiratory chain and appears to be 
essential for both its structural and functional integrity [15]. 
In yeast, mutational inactivation of m t A C P also leads to a 
respiratory-deficient phenotype although there exists no mito-
chondrial N A D H - u b i q u i n o n e oxidoreductase, in the organ-
ism [15]. Another type II FAS component enzyme, ß-ketoacyl 
synthase, has recently been localized to yeast mitochondria, 
too [16]. Since mutants of both the mitochondrial A C P and ß-
ketoacyl synthase elicit the same, respiratory-deficient pheno-
type it is suggested that both proteins primarily represent 
components of a mitochondrial FAS system and only indi-
rectly affect mitochondrial respiration. The availability of 
yeast mutants defective in cytoplasmic de novo fatty acid syn-
thesis [17] together with the identification of the mtACP-en-
coding D N A sequence [11] provided the opportunity to study 
this function in more detail. 
2. Materials and methods 
2.1. Strains and media 
The haploid Saccharomyces cerevisiae strains SC 1259 (MATa 
pral-1 prbl-1 prel-1 cpsl-3 ura3 leu2 hisll2 Afasl : :LEU2), SC 
1260 (MATa pral-1 prbl-1 prel-1 cpsl-3 ura3 leu2 hisll2 Afas2:: 
LEU2), SC 1294 (MATa leu2 his3 trpl ura3 Aacpl : :URA3), SC 1332 
(Mata Afas2::LEU2 Aacpl ::URA3) were from our own collection. 
Strains MYY 110 (MATa leu2 his3 rho"; M. Yaffe, La Jolla, CA), 
D8-22A/2 (MATa ade4 rho°; G. Michaelis, Düsseldorf, Germany) 
and JS 89.16 (diploid, ura3/ura3 Ieu2/leu2 his3/HIS3 trpl/TRPl; 
H.-J. Schriller, Erlangen, Germany) were kindly provided from other 
sources. For lipoic acid bioassays the E. coli mutant JRG33/CGSC 
No. 4286 was used [18]. Yeast cells were routinely grown in either 
fatty acid-free YEP media containing 0.5% yeast extract (Difco), 0.7% 
peptone (Difco) and 2% sucrose. Fatty acid-supplemented YEP-FA 
media contained, in addition, 0.5% Brij 58 (Fluka) and 0.015% of 
each 13:0 and 15:0 fatty acids (Sigma). Radioactive labelling of in 
vivo synthesized fatty acids was performed in YEP-FA medium con-
taining 100 uCi [1-14C] acetic acid (NEN; 2.0 GBq/mmol in ethanol). 
For lipoic acid bioassays, the basal media indicated by Herbert and 
Guest [18] was used with the additions listed by Sulo and Martin [19]. 
Respiratory competence of yeast strains was examined on YPG-FA 
solid media containing 1% yeast extract, 2% peptone, 3% glycerol, 1% 
Tween-40 and 2% agar. 
2.2. Plasmids and DNA manipulations 
The S. cerevisiae ACPI gene was isolated, as 2.7 kb XballBamWl 
fragment, from the plasmid pLMY 141 which was kindly provided by 
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L. Mattheakis, Palo Alto, CA [11]. After subcloning into pUCBM 
(Boehringer, Mannheim) the ACPI coding sequence was eliminated, 
together with its surrounding DNA, as a 0.87 kb Clal/Spel fragment 
and replaced by the yeast URA3 gene. This was derived from YDp-U 
[20] with intermediate subcloning into pBluescript (Stratagene). Sub-
sequently, the Xbal/BamHI DNA fragment containing the ac-
pl ::URA3 replacement was incorporated into the yeast genome by 
integrative transformation of the diploid strain, JS 89.16 [21]. After 
sporulation, the acpl deletion mutant, SC 1294, was identified by its 
URA3 prototrophy and subsequently verified by PCR analysis. PCR 
analysis of ACPI wild-type and mutant alleles was performed using 
the oligonucleotides 5'-GATGAAGTCAGGATTTGTATC-3' (ACP-
B) and 5'-ACGATCTTTCAACGCTGCCAC-3' (ACP-A) as primers. 
The respective products eventually exhibiting a length difference of 0.5 
kb were inspected by agarose gel electrophoresis. 
2.3. Lipoic acid analysis 
Yeast cultures were grown for 24-36 h at 30°C in 25 ml of YEP 
media under occasional shaking. The harvested cells were thoroughly 
washed and subsequently hydrolyzed with 1.0 ml of 9 N H2SO4 for 2 h 
at 120°C. The hydrolysate was neutralized with 10 N NaOH and 
subsequently centrifuged for 30 min at 15000Xg. Remaining insolu-
ble material was removed by filtration through glass wool. Aliquots of 
the filtrate were used for lipoic acid bioassays employing the lipoic 
acid requiring E. coli strain, JRG33/CGSC 4286 [18]. Assays were 
conducted with duplicates of two different aliquots from each sample. 
The aliquots were chosen to fit into the initial, linear range of the 
lipoic acid standard plot. Extracts containing very low levels of lipoic 
acid were re-assayed in the presence of known amounts of lipoic acid 
thereby excluding the interference of inhibitors. The hydrolysis and 
storage procedures used were tested with known amounts of lipoic 
Table 1 
Meiotic co-segregation of the acpl deletion with lipoic acid deficiency 
Complete tetrad 
ACP-negative spores 
from incomplete tetrads 
ACP-positive spores 
from incomplete tetrads 
Controls 
SC 1216 
MYY 110 
D8-22A/2 
SC 1294 
Tetrad No. 
4 
2 
1 8 
9 
10 
17 
18 
20 
22 
23 
2 
: 6 
8 
8 
9 
9 
10 
10 
11 
11 
13 
13 
14 
14 
15 
17 
17 
18 
19 
20 
21 
21 
21 
23 
26 
26 
27 
28 
(ACPI, rho+) 
(ACPI, rho") 
(ACPI, rho°) 
(Aacpl, rho - ) 
Sp 
A 
B 
C 
D 
A 
B 
C 
D 
D 
C 
B 
A 
B 
D 
A 
A 
C 
A 
D 
A 
C 
A 
D 
A 
B 
B 
D 
C 
A 
C 
A 
A 
C 
A 
C 
D 
C 
A 
B 
C 
C 
ore No. ACPI 
A 
A 
+ 
+ 
A 
A 
A 
A 
A 
A 
A 
A 
A 
URA3 
+ 
+ 
average 
average 
Lipoic acid 
(ng/g wet weight) 
48 
15 
270 
140 
16 
15 
22 
17 
20 
17 
14 
11 
7 
18 
340 
320 
310 
190 
210 
220 
170 
180 
490 
130 
180 
220 
530 
330 
210 
160 
190 
480 
150 
440 
160 
160 
460 
450 
290 
220 
310 
440 
280 
275 
250 
250 
34 
Diploids of the cross SC 1294X SCI296 were sporulated and subjected to tetrad analysis. Upon outgrowth on YEP-FA agar, viable spores were 
screened for respiratory competence and growth on uracil-free SC-media. Wild-type and deleted ACPI alleles were identified by PCR analysis. 
Lipoic acid bioassays were performed as described in Section 2. 
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acid and proved to show excellent recoveries. Lipoic acid concentra-
tions were correlated to cell densities (OD60o) of the individual yeast 
cultures. It was found that ODgoo=l-0 corresponded to 1.8 mg of wet 
weight yeast cells. 
2.4. Fatty acid analyses 
The fatty acid composition of total yeast lipids was determined 
using two different procedures depending on whether the cells had 
been radioactively labelled (B) or not (A). 
2.4.1. Procedure A. Lipids were extracted with chloroform/meth-
anol according to Folch et al. [22]. Subsequently, fatty acids were 
converted into methyl esters by treatment with methanol/BCl3 and 
analyzed on a 5890A Hewlett Packard gas Chromatograph equipped 
with a HP5 capillary column (nonpolar, 0.2 mmX25 m). 
2.4.2. Procedure B. Freeze-dried cells were hydrolyzed with 2 N 
HC1 in methanol at 90°C for 5 h. The methyl esters were extracted 
with hexane, the hexane layer was dried over anhydrous MgS04 and 
then evaporated to dryness. The methyl esters were redissolved in 50 
ul CS2 and analyzed by radio-gas chromatography as stated previ-
ously [23]. 
3. Results and discussion 
3.1. Inactivation of the Saccharomyces cerevisiae ACPI gene 
The putative mtACP coding sequence, ACPI, present on S. 
cerevisiae chromosome XI was replaced by the yeast URA3 
gene using the one-step gene disruption method of Rothstein 
[21]. Chromosomal integration of the replacement construct 
into the diploid strain, JS 89-16, was verified by Southern 
blotting with both URA3 and ACPI hybridization probes. 
Sporulation of the heterozygous diploid resulted in viable 
spores containing the acpl null mutation. One of the acpl 
null mutants, SC 1294, was backcrossed to the ACPI-positive 
strain, SC 1216, and after renewed sporulation, meiotic seg-
regation of the defective acpl allele was followed by tetrad 
analysis. Even though the number of complete tetrads com-
prising four viable spores was low, the acpl mutation clearly 
segregated 2:2 as was verified by both the URA3 phenotype 
and the ACP-1-specific PCR fragment patterns of the spores. 
Independent of the complexity and composition of the growth 
media used, the acpl null mutants were respiratory deficient 
exhibiting the well-known pleiotropy of rho-negative petites 
[24]. Neither individual fatty acids of chain lengths between 
8 and 18 carbon atoms nor a mixture of the fatty acids con-
tained in wild-type yeast lipids, were able to suppress this 
phenotype (data not shown). The acpl-induced rho-negative 
character exhibited a moderate suppressivity since not only 
the acpl-defective segregants but also about 50% of the 
ACPI-positive spores in the above cross were rho-negative 
petites. In accordance with their pleiotropic respiratory defi-
ciency, the low-temperature cytochrome spectra of acpl mu-
tants indicated, apart from a marginal amount of cytochrome 
c, the loss of essentially all mitochondrial cytochromes (data 
not shown). 
3.2. Fatty acid synthesis in acpl null mutants 
In yeast, the cytoplasmic type I fatty acid synthase is con-
sidered to be responsible for the bulk of cellular fatty acid 
synthesis [25]. Nevertheless, the existence of a mitochondrial 
FAS system contributing to this process to a certain extent 
could not be excluded, a priori. In order to identify any pos-
sible products of this mitochondrial system, the fatty acid 
profile of an acpl-negative mutant was compared, in the 
background of a cytoplasmic FAS deficiency (A fas2), to 
that of an ACPI-positive strain. Supplementation of the fatty 
acid-requiring mutants with the odd-chain-length acids, tride-
canoic (13:0) and pentadecanoic (15:0) acid was expected to 
uncover any even-chain-length fatty acids synthesized, de 
novo, by the mitochondrial FAS system. As is indicated in 
Table 1, the relative content of even-chain-length fatty acids 
in the fas2 mutants was extremely low (1-2%), under these 
conditions, and proved to be independent of a functional 
ACPI gene. This could be due to traces of even-chain-length 
fatty acids being present in the growth media or to the intro-
duction of these acids during the workup procedure. Experi-
ments employing the fas 1-mutant cells yielded a content of 
below 0.3% even-chain fatty acids. No significant labelling 
of these traces of even-chain acids by [14C]acetate could be 
detected (Table 1). On the other hand, enough label was in-
corporated into the odd-chain fatty acids (C-15 and C-17) to 
allow detection of even-chain fatty acid labelling at the 0.5-
1%) level (data not shown). 
These results strongly argue against the significance of mi-
tochondrial ACP and of the putative mitochondrial FAS sys-
tem for overall yeast fatty acid synthesis. It should be stressed, 
however, that uncommon fatty acids such as hydroxy-acids or 
shorter-chain-length homologues with less than 12 carbon 
atoms were not included in this analysis. Apart from fatty 
acid synthesis, phospholipid synthesis was also found to be 
qualitatively unaffected by the yeast acpl mutation (data not 
shown). Similar results have recently been reported by Har-
ington et al. [16] for the yeast mitochondrial ß-ketoacyl syn-
thase mutant, ceml, and by Schneider et al. [15] for the mi-
tochondrial ACP mutants of Neurospora crassa and yeast. In 
contrast to the above in vivo studies on yeast mitochondrial 
FAS, [14C]malonic acid was incorporated, in vitro, into long-
chain fatty acyl ACP esters when incubated with purified mi-
Table 2 
Effect of ACPI on de novo fatty acid synthesis in FAS-deficient yeast strains 
Strain 
SC 1260 
(Afas2 ACPI) 
SC 1332 
(Afas2 Aacpl) 
SC 1259 
(Afasl ACPI) 
Fatty acids (%) 
13:1 
— 
3 
13:0 
24 
41 
27 
15:1 
7 
17 
28 
15:0 
45 
35 
28 
16:1 
0.3 
0.5 
0.2 
16:0 
— 
_ 
17:1 
7 
4 
10 
17:0 
15 
2 
3 
18:1 
— 
_ 
18:0 
15 
0.5 
0.1 
odd 
98 
99 
99 
even 
1.8 
1.0 
0.3 
Strains SC 1260 and SC 1332 were grown in YEP media supplemented with 0.5% Brij 58 and 0.03% of each tridecanoic (13:0) and pentadecamoic 
(15:0) acid. Fatty acid composition was analyzed according to procedure A. 
Strain SC 1259 was grown in YEP-FA media containing per litre, 100 uCi sodium [1-14C] acetate (2.0 GBq/mmol). Radioactive fatty acids were 
analyzed according to procedure B. 
All cultures were grown on a shaker at 30°C and harvested at an OD60o between 4 and 5. 
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tochondria from Neurospora [23] or plants [28]. It remains to 
be shown whether these differences are due to the use of 
different organisms or to the different experimental conditions 
employed. 
3.3. Lipoic acid content of wild type and acpl-deficient yeast 
cells 
The failure to detect any long-chain fatty acyl derivatives, 
in vivo, as potential products of the yeast mitochondrial FAS 
system prompted us to concentrate on possible shorter-chain-
length products. Among these, octanoic acid and its deriva-
tive, lipoic acid, were considered as the most prominent can-
didates since in earlier studies of Mikolajczyk and Brody 
[23,26], octanoic acid was identified as one of the major prod-
ucts associated with N. crassa mtACP. Furthermore, data 
recently reported by Morris et al [27] suggested that in E. 
coli, lipoic acid biosynthesis implies ACP-bound intermedi-
ates. Thus, the lipoic acid content of yeast and its correlation 
to the functioning of mitochondrial ACP was investigated. 
For this, a large collection of ACP-positive and acp-1-defec-
tive segregants from a ACPl/acpl heterozygous cross were 
analyzed. The data obtained from one complete tetrad and 
from a large number of vital spores provided by a series of 
incomplete tetrads are listed in Table 2. Among a total of 11 
acpl-negative and 30 ACPI-positive spores investigated, a 
strict correlation between the functional status of ACPI and 
the cellular lipoic acid concentration was observed. The aver-
age lipoic acid content of acpl-defective cells was about 10-
20-fold lower than that of ACPl-positive cells. The residual 
lipoic acid found in the acpl deletion mutants is likely to 
originate from the growth medium which contained about 
60 ng/ml of the cofactor. As expected, the acpl-defect being 
determined by PCR analysis co-segregated in all cases with 
the URA3 wild-type allele which had been used for insertional 
inactivation of ACPI. As is evident from the normal lipoic 
acid level of the ACPl-positive petite mutants included in this 
study as a control, the rho-negative character, per se, is ob-
viously not responsible for the observed lipoic acid deficiency. 
Therefore, it is concluded that mitochondrial ACP, together 
with other components of the putative mitochondrial type II 
FAS system, is involved in lipoic acid biosynthesis. Very re-
cently, Wada et al. [28] came to the same conclusion when 
studying the incorporation of [14C]malonic acid into the H-
protein of mitochondria from Neurospora and plants. 
In yeast, the addition of lipoic acid to the growth medium 
cannot compensate for the block in endogenous lipoic acid 
synthesis. Other than in E. coli, free lipoic acid is either not 
activated in yeast, or it is not taken up into the mitochondrial 
compartment. Recently, Sulo and Martin [19] working with a 
lipoic acid-deficient yeast mutant affected in the lipoate syn-
thase gene, LIP5, came to the same conclusion. Both acpl 
and lip5 defective yeast mutants exhibit the same respira-
tory-deficient and non-supplementable phenotype. The role 
of lipoic acid as an essential cofactor of the two a-ketoacid 
dehydrogenase reactions in the tricarboxylic acid cycle suffi-
ciently explains the observed respiratory defect. The loss of 
mitochondrial DNA as the consequence of a nuclear pet-mu-
tation is a well-known phenomenon and may be correlated to 
the low-energy status of the mutant mitochondria. Consider-
ing the lack of NADH-ubiquinone oxidoreductase in yeast 
mitochondria, mtACP is excluded from functioning as an es-
sential structural component of this complex, as it is reported 
for N. crassa mtACP [15]. A possible involvement of yeast 
mtACP in 3-hydroxymyristic acid biosynthesis as was postu-
lated earlier for N. crassa mtACP [23,26] has not been exam-
ined, in this study. Thus, it remains to be investigated whether 
mitochondrial ACP still serves additional functions other than 
the biosynthesis of lipoic acid and its putative precursor, oc-
tanoic acid. 
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